跳至主要内容
临床试验/DRKS00013526
DRKS00013526招募中未知

Evaluation of suitable criteria for the therapy of uterine fibroids by MR-guided high-intensity focused ultrasound (MR-HIFU) - HIFU-Myom

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 75 人开始时间: 2018年5月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
Female

入选标准

  • 1. Age of at least 18 years.
  • 2. Current creatinine
  • 3. Indication for local ablative therapy by means of HIFU
  • 4. Accessibility of the fibroid / fibroids with HIFU
  • 5. Funaki Type I-II
  • 6. Signed declaration of consent with compliance incl. Follow-up treatment with compliance including follow-up treatment
  • 7. Size of fibroid <12 cm
  • 8. Exclusion of a leiomyosarcoma
  • 9. Signed declaration of consent

排除标准

  • 1. Taking Ulipristalacetat (Esmya) over the past 6 months
  • 2. General MRI contraindications (pacemakers, metal parts)
  • 3. contrast agent allergy
  • 4. Significantly reduced general condition
  • 5. Massive obesity (BMI> 40)
  • 6. Patients with mental / psychiatric disorders
  • 7. pregnancy
  • 8. intrauterine Device
  • 9. Funaki Type III-IV
  • 10. Pedunculated serous fibroid
  • 11. Detection of a Leiomyosarcoma

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验